4 active warrant series; nearest expiry 2027-12-30.
Compare this book against every issuer →4 option grants covering 9,013,260 shares (~5.6% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $1.60 | Dec 30, 2027* 461d | 1.5M | ITM | 0.9% | C$2.3M | Auto |
| option | $1.30 | Feb 28, 2029 887d | 2.3M | ITM | 1.4% | C$3.0M | Auto |
| option | $1.81 | Feb 28, 2030 1252d | 2.4M | ITM | 1.5% | C$4.3M | Auto |
| option | $1.56 | Feb 28, 2031 1617d | 2.9M | ITM | 1.8% | C$4.5M | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
161,796,891 shares outstanding, plus 0 from warrants and 9,013,260 from options — a fully diluted 170,810,151 shares, or ~5.6% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
4 active warrant series; nearest expiry 2027-12-30.
Compare this book against every issuer →4 option grants covering 9,013,260 shares (~5.6% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $1.60 | Dec 30, 2027* 461d | 1.5M | ITM | 0.9% | C$2.3M | Auto |
| option | $1.30 | Feb 28, 2029 887d | 2.3M | ITM | 1.4% | C$3.0M | Auto |
| option | $1.81 | Feb 28, 2030 1252d | 2.4M | ITM | 1.5% | C$4.3M | Auto |
| option | $1.56 | Feb 28, 2031 1617d | 2.9M | ITM | 1.8% | C$4.5M | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
161,796,891 shares outstanding, plus 0 from warrants and 9,013,260 from options — a fully diluted 170,810,151 shares, or ~5.6% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
